Genenta Science SPA - ADRGNTA
13F holders, Q3 2024 (September 30)5holders
0new positions
0sold out
$4.21avg. 13F price*
At the end of Q3 2024, 5 institutions reported holding Genenta Science SPA - ADR (GNTA) in their 13F filings, unchanged from Q2 2024. 0 opened new positions and 0 sold out. The largest holders were AlTi Global, Inc. ($855K), Allianz SE ($441K) and Algebris (uk) Ltd. ($170K).
- Company
- Genenta Science SPA - ADR
- CUSIP
- 36870W100
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 11,019 shares bought, net +11,019 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| AlTi Global, Inc. | 0.02% | No change | 200,288 | $855K |
| Allianz SE | 0.01% | Add +10.8% | 103,250 | $441K |
| Algebris (uk) Ltd. | 0.07% | No change | 45,000 | $170K |
| UBS Group AG | 0.00% | Add +108.5% | 1,862 | $8K |
| Morgan Stanley | 0.00% | No change | 500 | $2K |
"% of holder's portfolio" is GNTA's weight in each manager's 13F, not the share of Genenta Science SPA - ADR the manager owns.